UK
Willetts champions UK life sciences
June 25, 2014Research and Development, Sales and Marketing BIA, BIO, Steve Bates, UK, Willetts, life sciences, san diego
Science minister David Willetts has been banging the drum for UK life sciences at a major conference in the US, …
India ‘likely’ to increase price caps
June 25, 2014Manufacturing and Production, Sales and Marketing China, FDA, India, UK, pricing
India’s government is ‘likely’ to increase the number of drugs which are subject to price caps, according to a report …
Dementia research ‘achingly slow’
June 20, 2014Research and Development, Sales and Marketing Alzheimer's, Cameron, Parkinson's, Parkinsons, UK, billings, dementia, research
The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …
Child flu pilot ‘encouraging’
June 9, 2014Research and Development, Sales and Marketing UK, Vaccine, chid, children, flu, government, phd
Figures from the child flu vaccine pilot launched last year by Public Health England (PHE) are encouraging, the government says. …
NHS Confederation: ‘ring-fence NHS funding’
June 5, 2014Sales and Marketing Mid Staffs, NHS Confederation, Rob webster, UK
The boss of the NHS Confederation has challenged political parties to ring-fence NHS funding for the next ten years. Rob …
Robert Francis QC joins Care Quality Commission
June 4, 2014Sales and Marketing Hunt, Mid Staffs, NHS, UK, rew, robert francis
Robert Francis QC is to join health watchdog the Care Quality Commission (CQC) as a non-executive director. Francis will be …
£47.5 million fund for UK life sciences
May 29, 2014Research and Development, Sales and Marketing European Investment Fund, Scottish Enterprise, Strathclyde Pension Fund, UK, epidarex, life sciences, lilly
A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …
GSK now faces UK investigation
May 28, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Poland, UK, bribery, corruption, iraq, sfo
The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …
AstraZeneca rejects Pfizer’s ‘final offer’
May 19, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover
AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …
Pfizer: ‘fewer scientists’ after merger
May 14, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover
Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …
Poll: UK opposed to Pfizer takeover bid of AZ
May 13, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research
The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …
AZ video: ‘Why we rejected Pfizer offer’
May 2, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, UK, buyout, merger, research
AstraZeneca has confirmed that it is not for turning when it comes to buyout offers from Pfizer and is happy …
Pfizer/AZ deal would put UK research in jeopardy
May 1, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, deal, merger, research
The UK’s medical research collective has come together to warn the government that any deal between US giant Pfizer and …
Biologics lift for UK
April 22, 2014Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc
Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …
How can ‘innovation’ be defined?
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma
Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
